CSI Market
Sign In | Register

Neuronetics Inc (STIM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access STIM Annual Cash Flow →
The quarterly cash flow data below helps track how Neuronetics Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-14.24
Depreciation & amortization2.27
Amortization of Other Assets2.78
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed-0.16
Inventories Decrease /-Increase1.29
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.37
Share-based Compensation2.37
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-0.54
Increase Decrease In Net Investment In Sales Type Leases-0.04
Cost Of Rental Units Purchased By Customers-
Capitalized Computer Software Impairments-
Transfer Of Inventory To Property And Equipment0.08
Capital Expenditures Incurred But Not Yet Paid-
Reduction Of Accounts Receivable In Long Term Note Receivable-
Increase Decrease In Contract With Customer Liability0.09
Increase Decrease In Contract With Customer Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.89
Increase (Decrease) in Accounts Payable1.57
Increase (Decrease) in Accrued Liabilities-3.39
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other0.65
Other Working Capital-0.09
Other Noncash Income (Expense)0.00
Other net-0.02
Payments for (Proceeds from) Other Operating Activities-1.66
Discontinued operations0.00
Net Cash flow from Operating Activities-10.43
Investing Activities
Capital Expenditures-0.61
Sale of Capital Items0.03
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Collection Issuance Of Notes Receivable-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.59
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.31
Long-term debt - borrowings0.00
Long-term debt - repayments-5.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-0.19
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net7.33
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents34.13
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.83
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-11.02
Total Cash Flow-9.19
4 historic quarters locked

Sign in to unlock the full Neuronetics Inc cash flow history.

Sign In Create Free Account

About Neuronetics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-094078

Figures are derived from filed reports and may be restated. Historical data is subject to revision.